| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.04 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |